Aizant – FDA approved key partner for Enorama Pharma

csm_aizant_small_0629660064

With Aizant’s production capacity and specialist expertise, the partnership looks at least on paper as a home run for Enorama.

Fast-growing Indian CRO company Aizant is with its FDA-approved development and production facilities a key partner for Swedish Enorama Pharma.

In short, the company is launching its first product, a nicotine gum that is to be produced with a unique compressed gum technology, into a global market starting in Europe. With Aizant’s production capacity and specialist expertise, paired with experience from hundreds of clinical development projects and international collaborations, the partnership looks at least on paper as a veritable home run for Enorama.

Read the full Biostock article in Swedish